Results 151 to 160 of about 148,834 (293)
Design and analysis strategies for robust microbiome ageing research
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens +8 more
wiley +1 more source
26 mars: Journée d'études "Réception et non-réception de Ptolémée au XII et XIIIe siècles" (SPHERE)
26 mars, salle Malevitch, 483A Réception et non-réception de Ptolémée au XII et XIIIe siècles Journée organisée par Barbara Obrist (CNRS, SPHERE) Dirk Grupe (Munich) Ptolemaic and non-Ptolemaic elements in Stephen of Antioch’s Liber Mamonis (mid ...
parimed
core +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
Migrantization of mobile EU citizens? Assessing the impact of political reception contexts on bureaucratic discrimination. [PDF]
Manatschal A +3 more
europepmc +1 more source
Réception au Palais Azem (ca 1925)
Réception au Palais Azem, première mise en ligne par l'Ifpo. Réception dans la grande cour du Palais Azem. Ca 1925. Un album Palais Azem est accessible dans la galerie de photos de l’Ifpo sur Flickr.
Jean-Christophe Peyssard
core
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Appraising the causal relationship between kidney function and hearing performance: a two-sample Mendelian randomization study. [PDF]
Huang W, Li Z, Zhang Y, Tan H, Shi J.
europepmc +1 more source
Séminaire — "Réception de l'Antiquité"
vendredi 3 avril 2015, salle F0.13, Maison de la Recherche, Lille 3 Séminaire de l'École doctorale-Lille, Réception de l'Antiquité, deuxième journée d'études => responsables : Ch.
IRHiS1
core

